Best foot forward: What you can do about your dry, cracked heels
HOW DO CRACKED HEELS DEVELOP?
Cracked heels are directly caused by dry skin. Dry skin loses its elasticity, which is why it is prone to peeling and splitting – when this happens, the cracks can lead to open wounds, or even infection if they are exposed to bacteria.
The first sign that cracked heels may develop is that the skin on the heels becomes thick and rough – you might even feel calluses on the skin and notice that it has a whitish or yellowish appearance.
So why does skin on the heels become dry or thick? Likely because you are either predisposed to having dry skin and you just aren't diligent about moisturising.
Certain medical conditions can also lead to it – these include diabetes and skin issues like eczema or psoriasis. Those who suffer from these conditions, or are on medication that causes dry skin, can be more prone to having cracked heels.
Being on your feet or walking barefoot for long periods of time is another contributing factor – the pressure and friction that the heels have to bear can cause skin on them to become hard and thick over time.
This also explains why certain types of shoes can cause cracked heels, too. They include unsupportive shoes or footwear that's made with hard, inflexible material that does little to ease the pressure and friction your feet have to withstand. Open-heeled footwear like slingbacks and sandals that expose your heels can also dry out the skin.
Finally, your weight can also be a factor that contributes to the problem – the heavier you are, the more the pressure your body is placing on your feet. This is also why some women get cracked heels during pregnancy.
HOW TO CARE FOR CRACKED HEELS
1. MOISTURISE, MOISTURISE, MOISTURISE
Going for regular pedicures will help, but there are easy ways to care for your heels at home if you'd rather not splurge on services.
Moisturising daily is essential. A foot cream that's made to target the thick skin on heels is ideal, although a regular body moisturiser will also do.
2. EXFOLIATION IS ALSO A MUST
This will slough away dead, dry skin, prevent the skin on heels from thickening and allow moisturisers to penetrate skin and hydrate it more effectively. Once or twice a week, go over your heels with a foot scrub or loofah, and then use a pumice stone to target calluses and areas with extra thick skin. Soaking your feet in warm water for about 15 minutes before you do so will help soften the skin on heels and make it easier to remove dead skin.
3. PROTECT THE HEELS
Avoid footwear that expose the heels so as to prevent skin from becoming dry. It's also important to wear supportive shoes – use padding inserts or heel insoles to provide the heels with adequate cushioning if necessary. Wearing socks will also help reduce abrasion against the skin when you're walking in shoes.
If you have split cracks on the heels, shield them with liquid bandage to protect wounds from coming into contact with germs and moisture.
4. LIMIT TIME SPENT WALKING OR STANDING
Reduce the time you spend walking and standing, as far as possible, will help keep cracked heels from developing or worsening.
5. SEEK PROFESSIONAL CARE
In severe cases, where there's extremely thick and dry skin on heels, or split cracks that are bleeding, painful, infected or inflamed, it's best to see a podiatrist.
A podiatrist can administer the appropriate medical care, such as providing prescription-strength ointments or creams, and perform the necessary bandaging or even debridement, which is the cutting away of extra thick and hard skin on the heels.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
12 hours ago
- CNA
Study attributes 440 'excess deaths' to January's Los Angeles wildfires
LOS ANGELES: Wildfires that devastated parts of the Los Angeles area in January indirectly led to hundreds of deaths in the ensuing weeks, far exceeding the official toll of 31 fatalities, according to a study released on Wednesday (Aug 6). The research, published in the Journal of the American Medical Association, or JAMA, estimated 440 "excess deaths" were attributable to the fires from Jan 5 to Feb 1, using models that compared predicted mortality under normal circumstances to actual numbers documented during that period. The additional deaths likely reflect a mix of factors, including increased exposure of people with heart and lung disease to poor air quality from smoke and toxins released by the fires, as well as healthcare delays and disruptions, the study said. The findings "underscore the need to complement direct fatalities estimates with alternative methods to quantify the additional mortality burden of wildfires and of climate-related emergencies more broadly," the researchers wrote. Two wind-driven wildfires that erupted during the first week of January on opposite sides of Los Angeles damaged or destroyed nearly 16,000 structures combined - laying waste to much of the seaside district of Pacific Palisades and the foothill community of Altadena. Together, the blazes scorched 152 sq km, an area larger than Paris. The official tally of people who perished as a direct result of the fires stands at 31, after the most recent set of human remains were unearthed in Altadena in July, six months after the fires. Governor Gavin Newsom in February requested nearly US$40 billion in wildfire aid from Congress. Some estimates put economic losses from the fires at more than US$250 billion, making the conflagration one of the most costly natural disasters in US history. The JAMA study acknowledged some limitations, saying the data may need to be revised upward in the future and the research did not reflect any fire-attributable deaths beyond Feb 1.
CNA
2 days ago
- CNA
US axes mRNA vaccine contracts, casting safety doubts
WASHINGTON: President Donald Trump's administration on Tuesday (Aug 5) announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the COVID-19 pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F Kennedy Jr, marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu", he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine - a move the company itself disclosed in May - as well as numerous other programmes, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly US$500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunisation, has overseen a major overhaul of US health policy - firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed - a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."
CNA
2 days ago
- CNA
Former X CEO Yaccarino takes helm at GLP-1 focused telehealth firm eMed
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, nearly a month after stepping down as CEO of social media platform X. Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive its reputation among advertisers, who were wary of the platform's content as well as the billionaire's steady stream of controversial posts. Although devoid of any experience in the health sector, she does bring in deep expertise in brand partnerships and digital revenue growth. At NBCUniversal, she modernized the global advertising business over a decade. At X, she helped regain advertiser confidence following turbulence under Musk's ownership. In her first public statement following her appointment, Yaccarino said, "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before." Gil Luria, an analyst at D.A. Davidson, said Yaccarino brings critical experience in consumer-focused digital platforms. "This new category of apps like Hims and LifeMD are mostly focused on the consumer Ms. Yaccarino's experience is in media, much of that has had to do with creating consumer engagement." Miami, Florida-based eMed, founded in 2020, partners with employers and government payers to manage GLP-1 usage, a class of obesity and diabetes drugs whose cost burden has been a barrier to a wider insurance coverage. The company claims its platform can cut costs of a weight loss program by up to 50 per cent, offering live, on-demand care without appointments. EMed gained traction during the pandemic with at-home COVID-19 tests and later expanded into diagnostics for strep throat and UTIs, though it has since moved away from those offerings.
